|
|
Article: Data on atopic eczema described by researchers at Children's Hospital, Department of Clinical Science.(Report)
- Article from:
- Biotech Week
- Article date:
- July 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Researchers detail in 'Enhanced expression of the antimicrobial peptide LL-37 in lesional skin of adults with atopic eczema,' new data in atopic eczema. "Atopic eczema (AE) is a common multifactorial chronic skin disease associated with a defective skin barrier and increased susceptibility to skin infections. The human cathelicidin LL-37 plays a role in the host defence of skin," investigators in Stockholm, Sweden report (see also Atopic Eczema).
"Studies have demonstrated deficient expression of LL-37 in skin of AE patients. The aim of this study was to investigate the expression of LL-37 in lesional skin compared with nonlesional skin in patients with different ...